JTC Employer Solutions Trustee Ltd Invests $26,000 in UiPath Inc. (NYSE:PATH)

JTC Employer Solutions Trustee Ltd bought a new position in UiPath Inc. (NYSE:PATH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,068 shares of the healthcare company’s stock, valued at approximately $26,000.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of UiPath by 5.6% in the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after buying an additional 2,133,078 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in UiPath by 0.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock valued at $6,696,000 after purchasing an additional 1,571 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in UiPath by 3,389.4% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 89,189 shares of the healthcare company’s stock valued at $1,131,000 after purchasing an additional 86,633 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its stake in UiPath by 4.2% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after purchasing an additional 9,393 shares in the last quarter. Finally, Acadian Asset Management LLC raised its stake in UiPath by 245.1% during the first quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after purchasing an additional 32,456 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on PATH shares. Wells Fargo & Company upped their price target on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday, September 6th. DA Davidson upped their price target on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Bank of America upped their price target on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. BMO Capital Markets boosted their price objective on shares of UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a research report on Friday, September 6th. Finally, Barclays boosted their price objective on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research report on Friday, September 6th. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $17.71.

UiPath Stock Performance

PATH stock opened at $13.07 on Friday. The firm has a market cap of $7.19 billion, a price-to-earnings ratio of -65.32 and a beta of 0.88. The firm has a 50-day simple moving average of $12.40 and a two-hundred day simple moving average of $14.46. UiPath Inc. has a one year low of $10.37 and a one year high of $27.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. UiPath’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the firm posted ($0.09) EPS. As a group, equities analysts predict that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 22.37% of the stock is currently owned by insiders.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.